⌘K
Loading ticker…
Omeros Corporation · Healthcare · Pharmaceutical Products
As of 2026-06-26, Omeros Corporation (OMER) has a 3-month relative strength percentile of 20 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 63. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.6%, relative volume 5.54×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
20 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
OMER is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $22M notional. Top 3 carry $48M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $22M |
| IWMiShares Russell 2000 ETF | 0.02% | $18M |
| VXFVanguard Extended Market ETF | 0.01% | $8M |
| IWOiShares Russell 2000 Growth ETF | 0.04% | $5M |
| XPHState Street SPDR S&P Pharmaceuticals ETF | 1.70% | $5M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | OMER Jan avg: -4.32% median: -6.83% win: 25% σ: 25.24% n: 4 2022-04-12 → 2026-05-29 | OMER Feb avg: 17.38% median: 16.54% win: 75% σ: 20.16% n: 4 2022-04-12 → 2026-05-29 | OMER Mar avg: -3.65% median: -7.31% win: 25% σ: 19.95% n: 4 2022-04-12 → 2026-05-29 | OMER Apr avg: 1.57% median: -8.70% win: 40% σ: 29.73% n: 5 2022-04-12 → 2026-05-29 | OMER May avg: -19.46% median: -24.38% win: 40% σ: 27.23% n: 5 2022-04-12 → 2026-05-29 | OMER Jun avg: 4.14% median: 3.99% win: 50% σ: 14.64% n: 4 2022-04-12 → 2026-05-29 (current) | OMER Jul avg: 30.70% median: 30.88% win: 75% σ: 41.31% n: 4 2022-04-12 → 2026-05-29 | OMER Aug avg: -13.48% median: -19.77% win: 25% σ: 14.03% n: 4 2022-04-12 → 2026-05-29 | OMER Sep avg: -11.15% median: -10.65% win: 0% σ: 9.27% n: 4 2022-04-12 → 2026-05-29 | OMER Oct avg: 6.59% median: 3.42% win: 75% σ: 56.48% n: 4 2022-04-12 → 2026-05-29 | OMER Nov avg: 65.46% median: 58.12% win: 75% σ: 91.20% n: 4 2022-04-12 → 2026-05-29 | OMER Dec avg: 29.80% median: 27.46% win: 75% σ: 41.01% n: 4 2022-04-12 → 2026-05-29 |